Previous Close | 93.84 |
Open | 94.15 |
Bid | 95.23 x 800 |
Ask | 95.44 x 900 |
Day's Range | 94.15 - 95.63 |
52 Week Range | 73.66 - 114.99 |
Volume | |
Avg. Volume | 156,011 |
Market Cap | 1.537B |
Beta (5Y Monthly) | 0.89 |
PE Ratio (TTM) | 30.50 |
EPS (TTM) | 3.11 |
Earnings Date | Jul 31, 2023 - Aug 04, 2023 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 113.86 |
Thermo Fisher's (TMO) OrbitrapTM AstralTM mass spectrometer enables accurate and exact quantification in proteomics laboratories.
The higher capital equipment revenues, procedural volumes return and an acceleration from the new business lines poise Hologic (HOLX) for future growth.
Investors are optimistic about Align Technology (ALGN) owing to expanding work-flow options of its leading iTero scanners.
ADUS vs. USPH: Which Stock Is the Better Value Option?
Illumina's (ILMN) PrimateAI-3D will be made broadly available to the genomics community integrated across Illumina Connected Software.
Within Haemonetics (HAE) Vascular Closure, growth is led by the opening of new accounts and increasing penetration to gain share in the top U.S. EP hospitals.
Charles River (CRL) will establish a CGMP testing lab at Wheeler's factory through latest partnership.
Bio-Rad's (BIO) process chromatography business witnesses a slowdown in the quarter due to tough comparisons and some softness in the bioprocessing market.
Boston Scientific (BSX) gains from strong improvement in organic sales, indicating a solid rebound in the legacy business.
The mean of analysts' price targets for Addus HomeCare (ADUS) points to a 28.6% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
Medtronic's (MDT) latest acquisition will increase its capacity to assist more individuals with diabetes worldwide within a single, seamless Medtronic support ecosystem.
Investors are optimistic about CVS Health (CVS) on continued growth across the entire range of insured and self-insured medical, pharmacy, dental and behavioral health products and services.
Addus HomeCare Corporation ( NASDAQ:ADUS ) shareholders might be concerned after seeing the share price drop 22% in the...
Thermo Fisher (TMO) latest expansion will enable it to better assist clients in accelerating their research, development and marketing of medications and vaccines in the Asia-Pacific region.
FRISCO, Texas, May 24, 2023--Addus HomeCare Corporation (Nasdaq: ADUS), a provider of home care services, today announced that Dirk Allison, Chairman and Chief Executive Officer, and Brian Poff, Executive Vice President and Chief Financial Officer, will participate in the 2023 Jefferies Healthcare Conference, which takes place June 7-9, 2023, in New York City.
Investors are optimistic about Zimmer Biomet (ZBH) on continued procedure recovery, solid execution and increasing traction around innovations.
QIAGEN is a one-stop shop for all research needs, including solutions for sample preparation, automation and bioinformatics with enzyme offering expansion.
Abbott (ABT) notes that using TactiFlex catheter can lead to reduced procedure times and better safety compared to the company's previous generation catheters.
Hologic's (HOLX) Panther Fusion SARS-CoV-2/Flu A/B/RSV assay is done using the fully-automated, high-throughput Panther Fusion system.
Abbott's (ABT) latest approval adds to its line-up of remote patient management and treatment tools that can support doctors more effectively.
STERIS (STE) competes for pharmaceutical, research and industrial customers against several large companies that have robust product portfolios and global reach.
Edwards Lifesciences' (EW) latest findings of the study confirm the value of the Edwards Benchmark programme for standardizing clinical pathways for patients undergoing TAVR in Europe.
Investors are optimistic about Omnicell (OMCL) on its strong execution of strategies, disciplined cost management and revenue timing.
ADUS vs. USPH: Which Stock Is the Better Value Option?
Within cardiac rhythm management, Medtronic's (MDT) pacing business continues to outperform the market, banking on strong global growth of its Micra leadless pacemaker family.